Treatment for the negative symptoms of schizophrenia
Synexus is conducting a clinical research study of an investigational medication for individuals who schizophrenia.
Qualified study participants will receive study-related care and the investigational study medication at no charge and may be compensated up to $800 for study-related time and travel. Compensation for caretakers may also be available.
You may qualify for this study if you:
- Are 18 to 55 years of age
- Have been diagnosed with schizophrenia for at least a year
- Have been consistently taking an approved antipsychotic medication for at least 8 weeks
Male or Female
Why take part?
Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.
Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.
Who is Synexus?
Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.
We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.
All Synexus studies are approved by an independent ethics committee.